InteKrin
Immune disorder research
InteKrin Therapeutics is a clinical-stage, privately held BioPharma company focused on developing and commercializing breakthrough therapeutics for neuroendocrine, metabolic, and immune disorders. Diseases such as diabetes, metabolic syndrome, and...Homepage: http://www.intekrin.com
Total money raised: $18.5M
94022
4300 El Camino Real, Suite 201
Los Altos
USA CA
Los Altos
USA CA
Phone: 650-941-5501
Updated on Jun 26, 2009
InteKrin at CrunchBase
InteKrin at CrunchBase
August, 2008
InteKrin raised $18.5M in a Series C round from Amgen Ventures, Skyline Ventures, Sofinnova Ventures, OrbiMed Advisors, Asset Management Company, Sears Capital Management, and Vivo Ventures
InteKrin raises $18.5M for continued work on diabetes drug 
deals.venturebeat.com